Top compounds associated with response to TAS2R41


Feature Type Standardized
Nominal ANOVA
mRNA TPCA-1 CTRPv2 pan-cancer AAC 0.093 0.003
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA lomeguatrib CTRPv2 pan-cancer AAC 0.11 0.003
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.003
mRNA cediranib CTRPv2 pan-cancer AAC 0.15 0.004
mRNA Doxorubicin gCSI pan-cancer AAC -0.14 0.004
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.004
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC 0.1 0.005
mRNA MLN2480 CTRPv2 pan-cancer AAC 0.15 0.005
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.005
Download CSV